[Misdiagnosis of Gaucher disease in real life: Retrospective study of the French Gaucher's disease registry].

Les erreurs diagnostiques de la maladie de Gaucher dans la vraie vie : étude rétrospective du Registre français de la Maladie de Gaucher.

Journal

La Revue de medecine interne
ISSN: 1768-3122
Titre abrégé: Rev Med Interne
Pays: France
ID NLM: 8101383

Informations de publication

Date de publication:
Feb 2023
Historique:
received: 27 12 2021
revised: 14 11 2022
accepted: 30 11 2022
pubmed: 21 1 2023
medline: 14 2 2023
entrez: 20 1 2023
Statut: ppublish

Résumé

Gaucher disease is an autosomal recessive genetic disorder. It is caused by a deficiency of the lysosomal enzyme, glucocerebrosidase which leads to an accumulation of glucosylceramide in the macrophages. Splenomegaly, hepatomegaly, cytopenias (anemia, thrombocytopenia) and bone disorders are the main symptoms. The diagnosis is often delayed, leading to unnecessary investigations and treatments, and delaying the specific treatment. The primary objective of our study was to establish, in patients who had a diagnostic delay of more than one year, the reported misdiagnoses before the final diagnosis. The secondary objectives were to investigate the risk factors associated with error and delayed diagnosis. Retrospective study including patients with Gaucher disease from the French Gaucher Disease Registry. Collection of data by a single investigator from a standardized form. Among 83 patients with a known diagnostic delay, 13 patients (15 %) had one or two misdiagnoses. These included osteo-articular diagnoses (osteomyelitis, osteoarthritis, arthritis, osteochondritis, rheumatic fever, n=8), haematological diagnoses (gestational thrombocytopenia, immunological thrombocytopenia, n=4), infectious diagnoses (visceral leishmaniasis, mononucleosis, n=2) and hemochromatosis. The osteo-articular and infectious diagnoses concerned the child and the adolescent while the haematological diagnoses and the hemochromatosis concerned the adult. No factors were found associated with misdiagnoses. Patients with a diagnostic delay greater than one year were less likely to have hepatosplenomegaly as the first symptom. There is a risk of diagnostic error related to phenotypic heterogeneity and lack of specificity of Gaucher disease symptoms. This study helps to better identify the misdiagnoses associated with Gaucher disease.

Identifiants

pubmed: 36669934
pii: S0248-8663(22)01154-7
doi: 10.1016/j.revmed.2022.11.012
pii:
doi:

Types de publication

English Abstract Journal Article

Langues

fre

Sous-ensembles de citation

IM

Pagination

55-61

Informations de copyright

Copyright © 2022 Société Nationale Française de Médecine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.

Auteurs

Y Perez (Y)

Service de médecine interne, CHRU de Tours, 2 boulevard Tonnelé, 37044 Tours cedex, France. Electronic address: yonatperez@gmail.com.

N Belmatoug (N)

Centre de référence des maladies lysosomales, hôpitaux universitaires Paris Nord-Val-de-Seine, CHU Paris Nord-Val de Seine, hôpital Beaujon, Assistance publique-Hôpitaux de Paris (AP-HP), 100, boulevard du Général-Leclerc, 92110 Clichy, France; Service de médecine interne, hôpital Beaujon, Paris, France.

M Bengherbia (M)

Centre de référence des maladies lysosomales, hôpitaux universitaires Paris Nord-Val-de-Seine, CHU Paris Nord-Val de Seine, hôpital Beaujon, Assistance publique-Hôpitaux de Paris (AP-HP), 100, boulevard du Général-Leclerc, 92110 Clichy, France; Service de médecine interne, hôpital Beaujon, Paris, France.

K Yousfi (K)

Centre de référence des maladies lysosomales, hôpitaux universitaires Paris Nord-Val-de-Seine, CHU Paris Nord-Val de Seine, hôpital Beaujon, Assistance publique-Hôpitaux de Paris (AP-HP), 100, boulevard du Général-Leclerc, 92110 Clichy, France; Service de médecine interne, hôpital Beaujon, Paris, France.

B Lioger (B)

Service de médecine interne et polyvalente, centre hospitalier Simone Veil, 1 mail Pierre-Charlot, Blois, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH